Research programme: small molecules - Zosano Pharma

Drug Profile

Research programme: small molecules - Zosano Pharma

Alternative Names: Epinephrine transdermal - Zosano Pharma; Fentanyl - Zosano Pharma; Granisetron - Zosano Pharma; Naratriptan - Zosano Pharma; Pentosan polysulfate - Zosano Pharma; Sumatriptan - Zosano Pharma; Zolmitriptan - Zosano Pharma

Latest Information Update: 02 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Zosano Pharma
  • Class Small molecules
  • Mechanism of Action Adrenergic receptor agonists; Cell membrane structure inhibitors; Opioid mu receptor agonists; Serotonin 1 receptor agonists; Serotonin 1B receptor agonists; Serotonin 1D receptor agonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Anaphylaxis; Chemotherapy-induced nausea and vomiting; Interstitial cystitis; Migraine; Pain; Thrombosis

Most Recent Events

  • 29 Sep 2015 Preclinical trials in Anaphylaxis in USA (Transdermal)
  • 29 Sep 2015 Preclinical trials in Chemotherapy induced nausea and vomiting in USA (Transdermal)
  • 29 Sep 2015 Preclinical trials in Interstitial cystitis in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top